Pancreatic Cancer Awareness Month is an annual initiative in the UK which is designed to increase awareness and raise funding for the continued fight against one of the deadliest of cancers. This is a field we at Combat Medical are actively working in. The Combat PRS+ (Peritoneal Recirculation System +Agitation) optimises HIPEC (hyperthermic intraperitoneal chemotherapy) with gemcitabine into pancreatic tumour cells. Following a successful pilot study, it will be used in a randomised, open phase II-III clinical trial.
What Happens During Pancreatic Cancer Awareness Month?
Throughout the whole of November, organisations, advocacy groups and individuals can join forces with the purpose of promoting early detection, helping to raise funds for innovative research, and improve treatment options. This concerted effort is what is needed to continue the fight against pancreatic cancer, which still remains extremely challenging to detect early and to treat, and both of these factors contribute to its high mortality rate.
November is a time for participating in events, sharing survivor stories, and raising vital funds, ensuring that pancreatic cancer receives the attention it deserves. This month serves as a reminder to check for symptoms, understand the risk factors, and spread awareness.
The Silent Killer
Pancreatic cancer is often referred to as the “silent killer” because its symptoms typically only appear when the cancer has reached an advanced stage. This stealthy progression makes it one of the most lethal cancers, with a very low survival rate. It is especially deadly due to its location and the rapid rate at which it spreads, making treatment options very limited.
Symptoms and Risk Factors of Pancreatic Cancer
The symptoms of pancreatic cancer are often vague and can be mistaken for any number of illnesses. Common signs include jaundice, unexplained weight loss, and abdominal pain. Risk factors are similar to other cancers, i.e. genetic predisposition and lifestyle choices such as smoking and poor diet. It is important that patients who have suspicious symptoms consult with their doctor as soon as possible, as the earlier pancreatic cancer is detected, the better.
Little Improvement in Survival Rates
With more than half of patients with pancreatic cancer dying within 3 months of diagnosis, these shocking statistics highlight the urgent need for more effective treatment options. Unlike other cancers, pancreatic cancer has seen only modest improvements in survival rates over the past few decades.
What Is Combat PRS+ and How Does It Work?
At Combat Medical, we are dedicated to developing effective and safe treatment options to improve the prognosis for pancreatic cancer patients. The Combat PRS+ is an advanced medical device that enhances the delivery of HIPEC therapy, a heated chemotherapy treatment aimed directly at tumour cells in the abdomen. By circulating and agitating gemcitabine, Combat PRS+ targets cancer cells more effectively than traditional methods. This innovative approach not only increases the potency of the treatment but also minimises side effects.
Our Clinical Trials
Combat Medical is currently advancing to the next phase of testing with a randomised, open phase II-III clinical trial for Combat PRS+. Following a successful pilot study, this clinical trial is a significant step forward, aimed at validating the effectiveness and safety of Combat PRS+ for broader patient use. Clinical trials like this offer hope for new treatments and bring us closer to life-saving innovations. While challenges obviously remain, we are hopeful that the future holds promise for those affected by pancreatic cancer.
How Can You Support Pancreatic Cancer Awareness Month?
There are many ways to contribute to Pancreatic Cancer Awareness Month. Whether by donating to cancer research foundations, participating in local awareness events, or sharing information on social media, every bit helps.
Pancreatic Cancer Awareness Month is more than just a calendar event – it’s a lifeline for patients, families, and researchers. Our efforts, especially through innovations like Combat PRS+, bring to light the progress that is currently being made in this field. So, during the month of November, let’s both remember those who have lost their lives to this cruel disease, whilst remembering that increased awareness, funding, and research are the keys to changing the future of pancreatic cancer treatment for generations to come.
